Cargando…
Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725132/ https://www.ncbi.nlm.nih.gov/pubmed/33310109 http://dx.doi.org/10.1016/j.ijid.2020.12.006 |
_version_ | 1783620650127065088 |
---|---|
author | Linschoten, Marijke Nab, Linda van der Horst, Iwan C.C. Tieleman, Robert Asselbergs, Folkert W. |
author_facet | Linschoten, Marijke Nab, Linda van der Horst, Iwan C.C. Tieleman, Robert Asselbergs, Folkert W. |
author_sort | Linschoten, Marijke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7725132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77251322020-12-10 Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” Linschoten, Marijke Nab, Linda van der Horst, Iwan C.C. Tieleman, Robert Asselbergs, Folkert W. Int J Infect Dis Letter to the Editor The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-02 2020-12-09 /pmc/articles/PMC7725132/ /pubmed/33310109 http://dx.doi.org/10.1016/j.ijid.2020.12.006 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Linschoten, Marijke Nab, Linda van der Horst, Iwan C.C. Tieleman, Robert Asselbergs, Folkert W. Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” |
title | Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” |
title_full | Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” |
title_fullStr | Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” |
title_full_unstemmed | Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” |
title_short | Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients” |
title_sort | response to “early hydroxychloroquine but not chloroquine use reduces icu admission in covid-19 patients” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725132/ https://www.ncbi.nlm.nih.gov/pubmed/33310109 http://dx.doi.org/10.1016/j.ijid.2020.12.006 |
work_keys_str_mv | AT linschotenmarijke responsetoearlyhydroxychloroquinebutnotchloroquineusereducesicuadmissionincovid19patients AT nablinda responsetoearlyhydroxychloroquinebutnotchloroquineusereducesicuadmissionincovid19patients AT vanderhorstiwancc responsetoearlyhydroxychloroquinebutnotchloroquineusereducesicuadmissionincovid19patients AT tielemanrobert responsetoearlyhydroxychloroquinebutnotchloroquineusereducesicuadmissionincovid19patients AT asselbergsfolkertw responsetoearlyhydroxychloroquinebutnotchloroquineusereducesicuadmissionincovid19patients |